Indirect Treatment Comparison of Biologics in Chronic Rhinosinusitis with Nasal Polyps
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Indirect Treatment Comparison of Biologics in Chronic Rhinosinusitis with Nasal Polyps
Authors
Keywords
-
Journal
Journal of Allergy and Clinical Immunology-In Practice
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-02-06
DOI
10.1016/j.jaip.2021.01.031
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics. A National Institute of Allergy and Infectious Diseases Workshop
- (2020) Robert Naclerio et al. Journal of Allergy and Clinical Immunology-In Practice
- Endotypes of Chronic Rhinosinusitis with Nasal Polyps: Pathology and Possible Therapeutic Implications
- (2020) Claus Bachert et al. Journal of Allergy and Clinical Immunology-In Practice
- Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials
- (2020) Philippe Gevaert et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The Global Allergy and Asthma European Network (GALEN rhinosinusitis cohort: a large European cross-sectional study of chronic rhinosinusitis patients with and without nasal polyps
- (2019) A. Khan et al. RHINOLOGY
- Twelve-year follow-up study after endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyposis
- (2019) Lien Calus et al. Clinical and Translational Allergy
- IL-33 blockade impacts mediators of persistence and exacerbation in a model of chronic airway inflammation
- (2019) Jeanne Allinne et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
- (2019) Claus Bachert et al. LANCET
- Disease Burden of Chronic Rhinosinusitis (CRS) is as Severe as Other Serious Chronic Diseases
- (2018) Eric J. Schenkel et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps
- (2018) Steven F. Weinstein et al. Journal of Allergy and Clinical Immunology-In Practice
- Highlights of eosinophilic chronic rhinosinusitis with nasal polyps in definition, prognosis, and advancement
- (2018) Hongfei Lou et al. International Forum of Allergy & Rhinology
- Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial
- (2017) Claus Bachert et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Sleep quality improves with endoscopic sinus surgery in patients with chronic rhinosinusitis and nasal polyposis
- (2017) M. Varendh et al. RHINOLOGY
- Emerging Endotypes of Chronic Rhinosinusitis and Its Application to Precision Medicine
- (2017) Dae Woo Kim et al. Allergy Asthma & Immunology Research
- Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease
- (2017) Whitney W. Stevens et al. Journal of Allergy and Clinical Immunology-In Practice
- Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis
- (2016) Claus Bachert et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Heterogenous Inflammation in Chronic Rhinosinusitis without Nasal Polyps
- (2016) Atsushi Kato et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers
- (2016) Peter Tomassen et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease
- (2015) Whitney W. Stevens et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Altered Quality of Life and Psychological Health (SCL-90-R) in Patients With Chronic Rhinosinusitis With Nasal Polyps
- (2015) Jae Ho Chung et al. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY
- Targeting key proximal drivers of type 2 inflammation in disease
- (2015) Namita A. Gandhi et al. NATURE REVIEWS DRUG DISCOVERY
- A pilot study of symptom profiles from a polyp vs an eosinophilic-based classification of chronic rhinosinusitis
- (2015) Christopher F. Thompson et al. International Forum of Allergy & Rhinology
- A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis
- (2015) J.M. Pinto RHINOLOGY
- The Importance of Local Eosinophilia in the Surgical Outcome of Chronic Rhinosinusitis: A 3-Year Prospective Observational Study
- (2014) Stephan Vlaminck et al. American Journal of Rhinology & Allergy
- ICON: chronic rhinosinusitis
- (2014) Claus Bachert et al. World Allergy Organization Journal
- Prevalence of sinonasal outcome test (SNOT-22) symptoms in patients undergoing surgery for chronic rhinosinusitis in the England and Wales National prospective audit
- (2012) S. Abdalla et al. CLINICAL OTOLARYNGOLOGY
- Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma
- (2012) Philippe Gevaert et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Role of frontal sinus surgery in nasal polyp recurrence
- (2012) Ahmed Bassiouni et al. LARYNGOSCOPE
- Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis
- (2011) Philippe Gevaert et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Psychometric validity of the 22-item Sinonasal Outcome Test
- (2009) C. Hopkins et al. CLINICAL OTOLARYNGOLOGY
- Sleep impairment in allergic rhinitis, rhinosinusitis, and nasal polyposis
- (2008) Timothy J. Craig et al. AMERICAN JOURNAL OF OTOLARYNGOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More